Table 1 MIC (μg/mL) of selected antibiotics against Staphylococcus aureus in a half MIC of levofloxacin (LVX) or oxacillin (OXA)
Antibiotic | S. aureus KACC 10778 | S. aureus ATCC 15564 | S. aureus CCARM 3080 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Control | LVX | OXA | Control | LVX | OXA | Control | LVX | OXA |
Ampicillin | 0.25(S) | 0.125 | 0.25 | 32(R) | 8 | 4 | 256(R) | <1 | 16 |
Cefoxitin | 2(S) | 0.5 | 0.5 | 4(S) | 1 | 0.25 | >512(R) | <1 | 32 |
Ceftazidime | 8(R) | 2 | 4 | 16(R) | 16 | 4 | 512(R) | 4 | 128 |
Ceftriaxone | 2(R) | 1 | 1 | 4(R) | 1 | 0.25 | >512(R) | <2 | 512 |
Chloramphenicol | 8(S) | 8 | 4 | 8(S) | 4 | 4 | 16(I) | 4 | 8 |
Ciprofloxacin | 0.5(S) | 0.125 | 0.25 | 0.5(S) | 0.25 | 0.125 | 32(R) | 1 | 8 |
Gentamicin | 1(S) | 0.5 | 1 | 16(R) | 2 | 1 | >512(R) | 128 | 256 |
Imipenem | 2(S) | 1 | 1 | 0.25(S) | 1 | 1 | >512(R) | 8 | >512 |
Levofloxacin | 0.25(S) | – | 0.125 | 0.25(S) | – | 0.0625 | 32(R) | – | 4 |
Meropenem | 0.125(S) | 0.0313 | 0.0313 | 0.125(S) | 0.0625 | 0.0313 | 64(R) | <1 | 8 |
Norfloxacin | 2(S) | 0.5 | 1 | 1(S) | 0.5 | 0.5 | 32(R) | 2 | 8 |
Oxacillin | 0.25(S) | 0.0625 | – | 0.25(S) | 0.125 | – | >512(R) | <1 | – |
Streptomycin | 8(R) | 4 | 4 | 64(R) | 32–16 | 4 | 128(R) | 512 | 4 |
Tetracycline | 0.5(S) | 0.5 | 0.5 | 0.25(S) | 0.25 | 0.25 | 64(R) | 16 | 32 |
Vancomycin | 2(S) | 0.5 | 0.5 | 2(S) | 0.5 | 0.5 | 2(S) | 2 | 0.5 |